PGS Sample Set (PSS): PSS009508

Phenotype eGFR<60 mL/min/1.73m2 used to define CKD (stage 3 or greater)
Sample Ancestry European

Sample Numbers

Total number
141,247 individuals
Detailed numbers
23,364 cases (16.54%)
117,883 controls
0.5% Male samples
Age of Study Participants Mean : 61.59 years
Number of Cohort(s) 3
Sample distribution
Sample gender distribution

Cohort(s)

Cohort Short Name Cohort Full Name Previous/other/additional names (e.g. sub-cohorts)
BioMe BioMe® BioBank Program (Institute for Personalized Medicine at the Icahn School of Medicine at Mount Sinai) BioMe Biobank (BMBB), MT. SINAI BioMe Biobank Platform (IMP), Charles R Bronfman Institute for Personalized Medicine - IPM / BioBank Genome Wide Association Study of Cardiovascular, Renal and Metabolic Phenotypes (IPM), Charles R Bronfman Institute for Personalized Medicine - IPM / BioBank Genome Wide Association Study of Cardiovascular, Renal and Metabolic Phenotypes I (IPM I), Charles R Bronfman Institute for Personalized Medicine - IPM / BioBank Genome Wide Association Study of Cardiovascular, Renal and Metabolic Phenotypes II (IPM II), IPM_EA_Affy, IPM_EA_Illu, Mount Sinai BioMe BioBank (Mount Sinai)
eMERGE Medical Records and Genomics study
UKB UK Biobank